Clinical Trial Update: A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 trial comparing LY900014 with insulin lispro (Humalog) in adults with type 1 diabetes; completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Humalog (insulin lispro)
• LY900014

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2020-05-14